Our current findings also raise exciting possibilities of novel treatment strategies for human alcoholic hepatitis utilizing pharmacological modulation of the endocrine adiponectin-FGF15/19 axis. The gene discussed is ADIPOQ; the disease is alcoholic hepatitis.